Unity Biotechnology Inc
(FRA:9U90)
€
0.973
0.069 (7.63%)
Market Cap: 16.15 Mil
Enterprise Value: 8.15 Mil
PE Ratio: 0
PB Ratio: 1.19
GF Score: 34/100 UNITY Biotechnology Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 11, 2020 / 08:40PM GMT
Release Date Price:
€76.65
(+1.86%)
Ross Howard Weinreb
Goldman Sachs Group Inc., Research Division - Research Analyst
Great. Good afternoon, everybody. My name is Ross Weiner, a biotechnology analyst at Goldman Sachs.
We're pleased to have UNITY Biotechnology with us today, and we'll kick it off.
Questions & Answers
Ross Howard Weinreb
Goldman Sachs Group Inc., Research Division - Research Analyst
Anirvan, you recently joined UNITY as the new CEO, it would be great if you can give us a brief introduction of yourself and your background and discuss with us what you found compelling about the opportunity at UNITY given your scientific background.
Anirvan Ghosh
Unity Biotechnology, Inc. - Director & CEO
Yes. Thanks, Ross. It's great to be here.
By a way of background, I've been at UNITY as CEO for a little over 2 months now. And immediately, before that, I was the Head of Research and Early Development at Biogen, where we -- I was accountable for the kind of early phase clinical studies. We had a pretty sizable
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot